1. |
Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature, 2000, 405(6785):421-424.
|
2. |
Reddy RC. Immunomodulatory role of PPAR-gama in alveolarm acrophages. J Investig Med, 2008, 56(2):522-527.
|
3. |
Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol, 1990, 21(6):607-612.
|
4. |
Zhang GY, Cheng T, Zheng MH, et al. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-betal and matrix production in human dermal fibroblasts. J Plast Reconstr Aesthet Surg, 2010, 63(7):1209-1216.
|
5. |
Wu M, Melichian DS, Chang E, et al. Rosiglitazong abrogates bleomycin-induced scleroderma and blocks profibrotic responses through PPAR-γ. Am J Pathol, 2009, 174(2):519-533.
|
6. |
Pascul G, Sullivan AL, Ogawa S, et al. Anti-inflammatory and antidiabetic roles of PPAR-gamma. Novartis Found Symp, 2007, 286:183-203.
|
7. |
潘晓娟, 张光峰, 董光富, 等.过氧化物酶体增殖物激活受体γ在结缔组织病相关的肺间质病变中抗纤维化作用机制研究.中华风湿病学杂志, 2013, 17(4):231-235.
|
8. |
刘强, 王超云, 马小松, 等.过氧化物酶体增殖物激活受体γ(PPAR-γ)与肝纤维化的研究进展.滨州医学院学报, 2013, 36(1):49-51.
|
9. |
Wang Z, Xu JP, Zheng YC, et al. Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats. Hepatob Pancreat Dis Int, 2011, 10(1):64-71.
|
10. |
康谊, 曾艳丽, 魏君锋, 等. PPARγ在大鼠肝纤维化形成过程中的动态变化.基础医学与临床, 2013, 33(10):1324-1325.
|
11. |
黄津, 张一. LX-2细胞中PPARγ对iNOS的影响及其抗肝纤维化作用.中国肝脏病杂志(电子版), 2015, 7(2):59-64.
|
12. |
Miyahara T, Schrum L, Rippe R, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem, 2000, 275(46):35715-35722.
|
13. |
Guo YT, Leng XS, Li T, et al. Effect of ligand of peroxisome proliferator-activated receptor gamma on biological characters of hepatic stellate cells. World J Gastroenterol, 2005, 11(30):4735-4739.
|
14. |
金国萍, 应利君, 童海明, 等.核受体PPARγ在醛固酮诱导大鼠急性肾损伤中的作用研究.浙江医学, 2015, 37(14):1196-1198, 1208.
|
15. |
李相友, 丁国华, 夏瑗瑜, 等.血管紧张素1-7对糖尿病大鼠肾小管间质纤维化的影响.中华肾脏病杂志, 2012, 28(10):798-803.
|
16. |
孙鹏.不同剂量PPARγ激动剂对非糖尿病肥胖小鼠血清脂联素、尿蛋白排泄及肾脏病理改变的相关性研究.天津:天津医科大学, 2014.
|
17. |
侯定善, 张晓梅.过氧化物酶体增生物激活受体γ及其激动剂在眼科疾病中的作用.中华实验眼科杂志, 2014, 32(10):954-960.
|
18. |
赵树梅, 李虹伟, 沈潞华.过氧化物酶体增殖物激活受体γ通路激活对糖尿病大鼠心肌纤维化的影响.中华老年多器官疾病杂志, 2010, 9(6):525-528.
|
19. |
聂树涛. PPARγ激动剂对增生性瘢痕成纤维细胞TGF-β1和Smad信号途径的作用研究.中国美容医学, 2011, 20(7):1098-1099.
|
20. |
张义鹏, 解学关, 高伟阳, 等. PPAR-γ在增生性瘢痕中的表达及意义.医学研究杂志, 2012, 41(4):145-148.
|